Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs

Exogenous vascular endothelial growth factor (VEGF) improves tissue perfusion in large animals and humans with chronic myocardial ischemia. Because tissue perfusion is mainly dependent on the arteriolar tree, we hypothesized that the neovascularizing effect of VEGF should include arteriogenesis, an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human gene therapy 2003-09, Vol.14 (14), p.1307-1318
Hauptverfasser: CROTTOGINI, Alberto, MECKERT, Patricia Cabeza, DE LORENZI, Andrea, TELAYNA, Juan, MELE, Anibal, FERNANDEZ, José L, MARANGUNICH, Laura, CRISCUOLO, Marcelo, CAPOGROSSI, Maurizio C, LAGUENS, Rubén, JANAVEL, Gustavo Vera, LASCANO, Elena, NEGRONI, Jorge, DEL VALLE, Héctor, DULBECCO, Eduardo, WERBA, Pablo, CUNIBERTI, Luis, MARTINEZ, Veronica
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1318
container_issue 14
container_start_page 1307
container_title Human gene therapy
container_volume 14
creator CROTTOGINI, Alberto
MECKERT, Patricia Cabeza
DE LORENZI, Andrea
TELAYNA, Juan
MELE, Anibal
FERNANDEZ, José L
MARANGUNICH, Laura
CRISCUOLO, Marcelo
CAPOGROSSI, Maurizio C
LAGUENS, Rubén
JANAVEL, Gustavo Vera
LASCANO, Elena
NEGRONI, Jorge
DEL VALLE, Héctor
DULBECCO, Eduardo
WERBA, Pablo
CUNIBERTI, Luis
MARTINEZ, Veronica
description Exogenous vascular endothelial growth factor (VEGF) improves tissue perfusion in large animals and humans with chronic myocardial ischemia. Because tissue perfusion is mainly dependent on the arteriolar tree, we hypothesized that the neovascularizing effect of VEGF should include arteriogenesis, an effect not as yet described in large mammalian models of myocardial ischemia. In the present study we investigated the effect of intramyocardial plasmid-mediated human VEGF(165) gene transfer (pVEGF(165)) on the proliferation of vessels with smooth muscle in a pig model of myocardial ischemia. In addition, we assessed the effect of treatment on capillary growth, myocardial perfusion, myocardial function and collateralization. Three weeks after positioning of an Ameroid constrictor (Research Instruments SW, Escondido, CA) in the left circumflex artery, pigs underwent basal perfusion (single-photon emission computed tomography [SPECT] with (99m)Tc-sestamibi) and regional function (echocardiography) studies at rest and under dobutamine stress, and were then randomly assigned to receive transepicardial injection of pVEGF(165) 3.8 mg (n = 8) or placebo (empty plasmid, n = 8). All experimental steps and data analysis were done in a blinded fashion. Five weeks later, pVEGF(165)-treated pigs showed a significantly higher density of small (8-50 microm in diameter) vessels with smooth muscle, higher density of capillaries, and improved myocardial perfusion. These results indicate an arteriogenic effect of VEGF in a large mammalian model of myocardial ischemia and encourage the use of VEGF to promote arteriolar growth in patients with severe coronary artery disease.
doi_str_mv 10.1089/104303403322319390
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75701527</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75701527</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-2e337a94481b3fe268a1ca01e29fb4153706405cb0be1d565c109ce5783c3c313</originalsourceid><addsrcrecordid>eNqFkU1r3DAQhkVoyVf7B3IoujQ3NxqNJa2PISRtINBLcjayPN5VkK2tZCcs_fPRkoUceig6aBDP-zCaYewCxA8Qq-YKRI0Ca4EoJUKDjThip6CUqUwt5adSF6AqhDxhZzk_CwGotDlmJ1ArgY3Wp-zvdZop-bimibLP3E_94qjn3a6Uc7LjLjqbem8Df7HZLcEmTlMf5w2F_eM6xdd5wwfr5pg4aMX3Jl6SUx4oFQl3mxQn72wIxZndhkbv-Nav8xf2ebAh09fDfc6e7m4fb35VD79_3t9cP1QOtZwrSYjGNnW9gg4HknplwVkBJJuhq0GhEboWynWiI-iVVg5E40iZFbpyAM_Z5bt3m-KfhfLcjqUPCsFOFJfcGmUEKGn-C0IDiFrtjfIddCnmnGhot8mPNu1aEO1-N-2_uymhbwf70o3Uf0QOyyjA9wNQJm3DUGbofP7gFJR_gsY3vlWXQA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19133651</pqid></control><display><type>article</type><title>Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><creator>CROTTOGINI, Alberto ; MECKERT, Patricia Cabeza ; DE LORENZI, Andrea ; TELAYNA, Juan ; MELE, Anibal ; FERNANDEZ, José L ; MARANGUNICH, Laura ; CRISCUOLO, Marcelo ; CAPOGROSSI, Maurizio C ; LAGUENS, Rubén ; JANAVEL, Gustavo Vera ; LASCANO, Elena ; NEGRONI, Jorge ; DEL VALLE, Héctor ; DULBECCO, Eduardo ; WERBA, Pablo ; CUNIBERTI, Luis ; MARTINEZ, Veronica</creator><creatorcontrib>CROTTOGINI, Alberto ; MECKERT, Patricia Cabeza ; DE LORENZI, Andrea ; TELAYNA, Juan ; MELE, Anibal ; FERNANDEZ, José L ; MARANGUNICH, Laura ; CRISCUOLO, Marcelo ; CAPOGROSSI, Maurizio C ; LAGUENS, Rubén ; JANAVEL, Gustavo Vera ; LASCANO, Elena ; NEGRONI, Jorge ; DEL VALLE, Héctor ; DULBECCO, Eduardo ; WERBA, Pablo ; CUNIBERTI, Luis ; MARTINEZ, Veronica</creatorcontrib><description>Exogenous vascular endothelial growth factor (VEGF) improves tissue perfusion in large animals and humans with chronic myocardial ischemia. Because tissue perfusion is mainly dependent on the arteriolar tree, we hypothesized that the neovascularizing effect of VEGF should include arteriogenesis, an effect not as yet described in large mammalian models of myocardial ischemia. In the present study we investigated the effect of intramyocardial plasmid-mediated human VEGF(165) gene transfer (pVEGF(165)) on the proliferation of vessels with smooth muscle in a pig model of myocardial ischemia. In addition, we assessed the effect of treatment on capillary growth, myocardial perfusion, myocardial function and collateralization. Three weeks after positioning of an Ameroid constrictor (Research Instruments SW, Escondido, CA) in the left circumflex artery, pigs underwent basal perfusion (single-photon emission computed tomography [SPECT] with (99m)Tc-sestamibi) and regional function (echocardiography) studies at rest and under dobutamine stress, and were then randomly assigned to receive transepicardial injection of pVEGF(165) 3.8 mg (n = 8) or placebo (empty plasmid, n = 8). All experimental steps and data analysis were done in a blinded fashion. Five weeks later, pVEGF(165)-treated pigs showed a significantly higher density of small (8-50 microm in diameter) vessels with smooth muscle, higher density of capillaries, and improved myocardial perfusion. These results indicate an arteriogenic effect of VEGF in a large mammalian model of myocardial ischemia and encourage the use of VEGF to promote arteriolar growth in patients with severe coronary artery disease.</description><identifier>ISSN: 1043-0342</identifier><identifier>EISSN: 1557-7422</identifier><identifier>DOI: 10.1089/104303403322319390</identifier><identifier>PMID: 14503966</identifier><identifier>CODEN: HGTHE3</identifier><language>eng</language><publisher>Larchmont, NY: Liebert</publisher><subject>Animals ; Biological and medical sciences ; Biotechnology ; Cardiotonic Agents - pharmacology ; Collateral Circulation - drug effects ; Coronary Angiography ; Coronary Vessels - drug effects ; Disease Models, Animal ; Dobutamine - pharmacology ; Echocardiography ; Fundamental and applied biological sciences. Psychology ; Gene Expression ; Gene therapy ; Gene Transfer Techniques ; Health. Pharmaceutical industry ; Immunohistochemistry ; Industrial applications and implications. Economical aspects ; Myocardial Ischemia - physiopathology ; Myocardial Ischemia - therapy ; Neovascularization, Physiologic - drug effects ; Stress, Physiological - chemically induced ; Swine ; Technetium Tc 99m Sestamibi ; Time Factors ; Tomography, Emission-Computed, Single-Photon ; Transgenes ; vascular endothelial growth factor ; Vascular Endothelial Growth Factor A - administration &amp; dosage ; Vascular Endothelial Growth Factor A - genetics ; Vascular Endothelial Growth Factor A - therapeutic use</subject><ispartof>Human gene therapy, 2003-09, Vol.14 (14), p.1307-1318</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-2e337a94481b3fe268a1ca01e29fb4153706405cb0be1d565c109ce5783c3c313</citedby><cites>FETCH-LOGICAL-c362t-2e337a94481b3fe268a1ca01e29fb4153706405cb0be1d565c109ce5783c3c313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3029,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15164016$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14503966$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CROTTOGINI, Alberto</creatorcontrib><creatorcontrib>MECKERT, Patricia Cabeza</creatorcontrib><creatorcontrib>DE LORENZI, Andrea</creatorcontrib><creatorcontrib>TELAYNA, Juan</creatorcontrib><creatorcontrib>MELE, Anibal</creatorcontrib><creatorcontrib>FERNANDEZ, José L</creatorcontrib><creatorcontrib>MARANGUNICH, Laura</creatorcontrib><creatorcontrib>CRISCUOLO, Marcelo</creatorcontrib><creatorcontrib>CAPOGROSSI, Maurizio C</creatorcontrib><creatorcontrib>LAGUENS, Rubén</creatorcontrib><creatorcontrib>JANAVEL, Gustavo Vera</creatorcontrib><creatorcontrib>LASCANO, Elena</creatorcontrib><creatorcontrib>NEGRONI, Jorge</creatorcontrib><creatorcontrib>DEL VALLE, Héctor</creatorcontrib><creatorcontrib>DULBECCO, Eduardo</creatorcontrib><creatorcontrib>WERBA, Pablo</creatorcontrib><creatorcontrib>CUNIBERTI, Luis</creatorcontrib><creatorcontrib>MARTINEZ, Veronica</creatorcontrib><title>Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs</title><title>Human gene therapy</title><addtitle>Hum Gene Ther</addtitle><description>Exogenous vascular endothelial growth factor (VEGF) improves tissue perfusion in large animals and humans with chronic myocardial ischemia. Because tissue perfusion is mainly dependent on the arteriolar tree, we hypothesized that the neovascularizing effect of VEGF should include arteriogenesis, an effect not as yet described in large mammalian models of myocardial ischemia. In the present study we investigated the effect of intramyocardial plasmid-mediated human VEGF(165) gene transfer (pVEGF(165)) on the proliferation of vessels with smooth muscle in a pig model of myocardial ischemia. In addition, we assessed the effect of treatment on capillary growth, myocardial perfusion, myocardial function and collateralization. Three weeks after positioning of an Ameroid constrictor (Research Instruments SW, Escondido, CA) in the left circumflex artery, pigs underwent basal perfusion (single-photon emission computed tomography [SPECT] with (99m)Tc-sestamibi) and regional function (echocardiography) studies at rest and under dobutamine stress, and were then randomly assigned to receive transepicardial injection of pVEGF(165) 3.8 mg (n = 8) or placebo (empty plasmid, n = 8). All experimental steps and data analysis were done in a blinded fashion. Five weeks later, pVEGF(165)-treated pigs showed a significantly higher density of small (8-50 microm in diameter) vessels with smooth muscle, higher density of capillaries, and improved myocardial perfusion. These results indicate an arteriogenic effect of VEGF in a large mammalian model of myocardial ischemia and encourage the use of VEGF to promote arteriolar growth in patients with severe coronary artery disease.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Biotechnology</subject><subject>Cardiotonic Agents - pharmacology</subject><subject>Collateral Circulation - drug effects</subject><subject>Coronary Angiography</subject><subject>Coronary Vessels - drug effects</subject><subject>Disease Models, Animal</subject><subject>Dobutamine - pharmacology</subject><subject>Echocardiography</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Expression</subject><subject>Gene therapy</subject><subject>Gene Transfer Techniques</subject><subject>Health. Pharmaceutical industry</subject><subject>Immunohistochemistry</subject><subject>Industrial applications and implications. Economical aspects</subject><subject>Myocardial Ischemia - physiopathology</subject><subject>Myocardial Ischemia - therapy</subject><subject>Neovascularization, Physiologic - drug effects</subject><subject>Stress, Physiological - chemically induced</subject><subject>Swine</subject><subject>Technetium Tc 99m Sestamibi</subject><subject>Time Factors</subject><subject>Tomography, Emission-Computed, Single-Photon</subject><subject>Transgenes</subject><subject>vascular endothelial growth factor</subject><subject>Vascular Endothelial Growth Factor A - administration &amp; dosage</subject><subject>Vascular Endothelial Growth Factor A - genetics</subject><subject>Vascular Endothelial Growth Factor A - therapeutic use</subject><issn>1043-0342</issn><issn>1557-7422</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1r3DAQhkVoyVf7B3IoujQ3NxqNJa2PISRtINBLcjayPN5VkK2tZCcs_fPRkoUceig6aBDP-zCaYewCxA8Qq-YKRI0Ca4EoJUKDjThip6CUqUwt5adSF6AqhDxhZzk_CwGotDlmJ1ArgY3Wp-zvdZop-bimibLP3E_94qjn3a6Uc7LjLjqbem8Df7HZLcEmTlMf5w2F_eM6xdd5wwfr5pg4aMX3Jl6SUx4oFQl3mxQn72wIxZndhkbv-Nav8xf2ebAh09fDfc6e7m4fb35VD79_3t9cP1QOtZwrSYjGNnW9gg4HknplwVkBJJuhq0GhEboWynWiI-iVVg5E40iZFbpyAM_Z5bt3m-KfhfLcjqUPCsFOFJfcGmUEKGn-C0IDiFrtjfIddCnmnGhot8mPNu1aEO1-N-2_uymhbwf70o3Uf0QOyyjA9wNQJm3DUGbofP7gFJR_gsY3vlWXQA</recordid><startdate>20030920</startdate><enddate>20030920</enddate><creator>CROTTOGINI, Alberto</creator><creator>MECKERT, Patricia Cabeza</creator><creator>DE LORENZI, Andrea</creator><creator>TELAYNA, Juan</creator><creator>MELE, Anibal</creator><creator>FERNANDEZ, José L</creator><creator>MARANGUNICH, Laura</creator><creator>CRISCUOLO, Marcelo</creator><creator>CAPOGROSSI, Maurizio C</creator><creator>LAGUENS, Rubén</creator><creator>JANAVEL, Gustavo Vera</creator><creator>LASCANO, Elena</creator><creator>NEGRONI, Jorge</creator><creator>DEL VALLE, Héctor</creator><creator>DULBECCO, Eduardo</creator><creator>WERBA, Pablo</creator><creator>CUNIBERTI, Luis</creator><creator>MARTINEZ, Veronica</creator><general>Liebert</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20030920</creationdate><title>Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs</title><author>CROTTOGINI, Alberto ; MECKERT, Patricia Cabeza ; DE LORENZI, Andrea ; TELAYNA, Juan ; MELE, Anibal ; FERNANDEZ, José L ; MARANGUNICH, Laura ; CRISCUOLO, Marcelo ; CAPOGROSSI, Maurizio C ; LAGUENS, Rubén ; JANAVEL, Gustavo Vera ; LASCANO, Elena ; NEGRONI, Jorge ; DEL VALLE, Héctor ; DULBECCO, Eduardo ; WERBA, Pablo ; CUNIBERTI, Luis ; MARTINEZ, Veronica</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-2e337a94481b3fe268a1ca01e29fb4153706405cb0be1d565c109ce5783c3c313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Biotechnology</topic><topic>Cardiotonic Agents - pharmacology</topic><topic>Collateral Circulation - drug effects</topic><topic>Coronary Angiography</topic><topic>Coronary Vessels - drug effects</topic><topic>Disease Models, Animal</topic><topic>Dobutamine - pharmacology</topic><topic>Echocardiography</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Expression</topic><topic>Gene therapy</topic><topic>Gene Transfer Techniques</topic><topic>Health. Pharmaceutical industry</topic><topic>Immunohistochemistry</topic><topic>Industrial applications and implications. Economical aspects</topic><topic>Myocardial Ischemia - physiopathology</topic><topic>Myocardial Ischemia - therapy</topic><topic>Neovascularization, Physiologic - drug effects</topic><topic>Stress, Physiological - chemically induced</topic><topic>Swine</topic><topic>Technetium Tc 99m Sestamibi</topic><topic>Time Factors</topic><topic>Tomography, Emission-Computed, Single-Photon</topic><topic>Transgenes</topic><topic>vascular endothelial growth factor</topic><topic>Vascular Endothelial Growth Factor A - administration &amp; dosage</topic><topic>Vascular Endothelial Growth Factor A - genetics</topic><topic>Vascular Endothelial Growth Factor A - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CROTTOGINI, Alberto</creatorcontrib><creatorcontrib>MECKERT, Patricia Cabeza</creatorcontrib><creatorcontrib>DE LORENZI, Andrea</creatorcontrib><creatorcontrib>TELAYNA, Juan</creatorcontrib><creatorcontrib>MELE, Anibal</creatorcontrib><creatorcontrib>FERNANDEZ, José L</creatorcontrib><creatorcontrib>MARANGUNICH, Laura</creatorcontrib><creatorcontrib>CRISCUOLO, Marcelo</creatorcontrib><creatorcontrib>CAPOGROSSI, Maurizio C</creatorcontrib><creatorcontrib>LAGUENS, Rubén</creatorcontrib><creatorcontrib>JANAVEL, Gustavo Vera</creatorcontrib><creatorcontrib>LASCANO, Elena</creatorcontrib><creatorcontrib>NEGRONI, Jorge</creatorcontrib><creatorcontrib>DEL VALLE, Héctor</creatorcontrib><creatorcontrib>DULBECCO, Eduardo</creatorcontrib><creatorcontrib>WERBA, Pablo</creatorcontrib><creatorcontrib>CUNIBERTI, Luis</creatorcontrib><creatorcontrib>MARTINEZ, Veronica</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Human gene therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CROTTOGINI, Alberto</au><au>MECKERT, Patricia Cabeza</au><au>DE LORENZI, Andrea</au><au>TELAYNA, Juan</au><au>MELE, Anibal</au><au>FERNANDEZ, José L</au><au>MARANGUNICH, Laura</au><au>CRISCUOLO, Marcelo</au><au>CAPOGROSSI, Maurizio C</au><au>LAGUENS, Rubén</au><au>JANAVEL, Gustavo Vera</au><au>LASCANO, Elena</au><au>NEGRONI, Jorge</au><au>DEL VALLE, Héctor</au><au>DULBECCO, Eduardo</au><au>WERBA, Pablo</au><au>CUNIBERTI, Luis</au><au>MARTINEZ, Veronica</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs</atitle><jtitle>Human gene therapy</jtitle><addtitle>Hum Gene Ther</addtitle><date>2003-09-20</date><risdate>2003</risdate><volume>14</volume><issue>14</issue><spage>1307</spage><epage>1318</epage><pages>1307-1318</pages><issn>1043-0342</issn><eissn>1557-7422</eissn><coden>HGTHE3</coden><abstract>Exogenous vascular endothelial growth factor (VEGF) improves tissue perfusion in large animals and humans with chronic myocardial ischemia. Because tissue perfusion is mainly dependent on the arteriolar tree, we hypothesized that the neovascularizing effect of VEGF should include arteriogenesis, an effect not as yet described in large mammalian models of myocardial ischemia. In the present study we investigated the effect of intramyocardial plasmid-mediated human VEGF(165) gene transfer (pVEGF(165)) on the proliferation of vessels with smooth muscle in a pig model of myocardial ischemia. In addition, we assessed the effect of treatment on capillary growth, myocardial perfusion, myocardial function and collateralization. Three weeks after positioning of an Ameroid constrictor (Research Instruments SW, Escondido, CA) in the left circumflex artery, pigs underwent basal perfusion (single-photon emission computed tomography [SPECT] with (99m)Tc-sestamibi) and regional function (echocardiography) studies at rest and under dobutamine stress, and were then randomly assigned to receive transepicardial injection of pVEGF(165) 3.8 mg (n = 8) or placebo (empty plasmid, n = 8). All experimental steps and data analysis were done in a blinded fashion. Five weeks later, pVEGF(165)-treated pigs showed a significantly higher density of small (8-50 microm in diameter) vessels with smooth muscle, higher density of capillaries, and improved myocardial perfusion. These results indicate an arteriogenic effect of VEGF in a large mammalian model of myocardial ischemia and encourage the use of VEGF to promote arteriolar growth in patients with severe coronary artery disease.</abstract><cop>Larchmont, NY</cop><pub>Liebert</pub><pmid>14503966</pmid><doi>10.1089/104303403322319390</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1043-0342
ispartof Human gene therapy, 2003-09, Vol.14 (14), p.1307-1318
issn 1043-0342
1557-7422
language eng
recordid cdi_proquest_miscellaneous_75701527
source Mary Ann Liebert Online Subscription; MEDLINE
subjects Animals
Biological and medical sciences
Biotechnology
Cardiotonic Agents - pharmacology
Collateral Circulation - drug effects
Coronary Angiography
Coronary Vessels - drug effects
Disease Models, Animal
Dobutamine - pharmacology
Echocardiography
Fundamental and applied biological sciences. Psychology
Gene Expression
Gene therapy
Gene Transfer Techniques
Health. Pharmaceutical industry
Immunohistochemistry
Industrial applications and implications. Economical aspects
Myocardial Ischemia - physiopathology
Myocardial Ischemia - therapy
Neovascularization, Physiologic - drug effects
Stress, Physiological - chemically induced
Swine
Technetium Tc 99m Sestamibi
Time Factors
Tomography, Emission-Computed, Single-Photon
Transgenes
vascular endothelial growth factor
Vascular Endothelial Growth Factor A - administration & dosage
Vascular Endothelial Growth Factor A - genetics
Vascular Endothelial Growth Factor A - therapeutic use
title Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T18%3A14%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Arteriogenesis%20induced%20by%20intramyocardial%20vascular%20endothelial%20growth%20factor%20165%20gene%20transfer%20in%20chronically%20ischemic%20pigs&rft.jtitle=Human%20gene%20therapy&rft.au=CROTTOGINI,%20Alberto&rft.date=2003-09-20&rft.volume=14&rft.issue=14&rft.spage=1307&rft.epage=1318&rft.pages=1307-1318&rft.issn=1043-0342&rft.eissn=1557-7422&rft.coden=HGTHE3&rft_id=info:doi/10.1089/104303403322319390&rft_dat=%3Cproquest_cross%3E75701527%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19133651&rft_id=info:pmid/14503966&rfr_iscdi=true